During the same period, sales of antibiotic classes that are considered critically important in human medicine for veterinary use noticeably decreased: sales of third- and fourth- generation cephalosporins dropped by 49%, polymyxins by 81%, fluoroquinolones by 25% and sales of other quinolones dropped by 90%. While all antibiotics should be used prudently and responsibly to preserve their effectiveness, it is of particular importance for these antibiotics to mitigate the potential risk to public health, as indicated in the Antimicrobial Advice ad hoc Expert Group (AMEG) categorisation.
"The collection of data on sales of veterinary antimicrobials has been critical in shaping policy initiatives, assessing the impact of current measures and setting objectives that assist in tackling the emergence of antimicrobial resistance,” said Ivo Claassen, Head of EMA’s Veterinary Medicines Division.
The article is refereed from EMA's website. Read more.
